![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 17/00 | (2006.01) |
A61K 38/47 | (2006.01) | ||
A61K 38/48 | (2006.01) | ||
A61K 38/46 | (2006.01) | ||
A61P 31/04 | (2006.01) |
(11) | Patento numeris | 2947100 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15152332.1 |
Europos patento paraiškos padavimo data | 2010-01-06 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
142718 P | 2009-01-06 | US | |
153279 P | 2009-02-17 | US | |
170856 P | 2009-04-20 | US |
(72) |
Fallon, Joan M., US
Heil, Matthew, US
Fallon, James J., US
|
(73) |
Galenagen, LLC,
411 Theodore Fremd Avenue, Suite 206, Rye, NY 10580,
US
|
(54) | Oral compositions for the treatment or the prevention of infections by E. Coli |
Oral compositions for the treatment or the prevention of infections by E. Coli |